AKYA - Akoya Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AKYA is currently covered by 8 analysts with an average price target of $5.1. This is a potential upside of $3.88 (318.03%) from yesterday's end of day stock price of $1.22.

Akoya Biosciences's activity chart (see below) currently has 21 price targets and 47 ratings on display. The stock rating distribution of AKYA is 86.67% BUY and 13.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 3.61% with an average time for these price targets to be met of 12.67 days.

Highest price target for AKYA is $3.5, Lowest price target is $1.65, average price target is $5.91.

Most recent stock forecast was given by DAVID WESTENBERG from PIPER SANDLER on 14-Apr-2025. First documented stock forecast 11-May-2021.

Currently out of the existing stock ratings of AKYA, 26 are a BUY (86.67%), 4 are a HOLD (13.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.65

$0.35 (26.92%)

$3

19 days ago
(14-Apr-2025)

2/11 (18.18%)

$0.4 (32.00%)

52

Buy

$1.8

$0.5 (38.46%)

$3.5

1 months 8 days ago
(25-Mar-2025)

0/5 (0%)

$0.26 (16.88%)

Buy

$3.5

$2.2 (169.23%)

$6

5 months 18 days ago
(15-Nov-2024)

0/5 (0%)

$1.09 (45.23%)

Buy

$3

$1.7 (130.77%)

$4

8 months 27 days ago
(06-Aug-2024)

1/7 (14.29%)

$0.99 (49.25%)

62

Hold

$6

8 months 27 days ago
(06-Aug-2024)

0/6 (0%)

$3.1 (106.90%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKYA (Akoya Biosciences) average time for price targets to be met?

On average it took 12.67 days on average for the stock forecasts to be realized with a an average price target met ratio 3.61

Which analyst has the current highest performing score on AKYA (Akoya Biosciences) with a proven track record?

DAVID WESTENBERG

Which analyst has the current lower performing score on AKYA (Akoya Biosciences) with a proven track record?

RACHEL VATNSDAL

Which analyst has the most public recommendations on AKYA (Akoya Biosciences)?

David Westenberg works at PIPER SANDLER and has 17 price targets and 10 ratings on AKYA

Which analyst is the currently most bullish on AKYA (Akoya Biosciences)?

Steven Mah with highest potential upside - $23.35

Which analyst is the currently most reserved on AKYA (Akoya Biosciences)?

Mark Massaro with lowest potential downside - -$0

Akoya Biosciences in the News

Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?

Zealand Pharma A/S (ZLDPF) shares ended the last trading session 8% higher at $72.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock’s 0.3% loss over the past four weeks. Last month, the company announced that it has enrolled the first...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?